KKR Not Immune to Private-Credit Headwinds -- Market Talk

Dow Jones
03/20

0746 GMT - KKR isn't immune to the headwinds facing the private-credit market, writes Morningstar's Greggory Warren in a note. Issues around liquidity in private-credit funds are likely to hit fundraising efforts and lead to increased redemption requests in the medium term, he says. While the alternative asset manager's exposure to private credit is far less than that of its peers Blue Owl and Ares, the company has enough private-credit exposure to weigh on it for the next several years, he adds. Morningstar cuts its fair-value estimate on KKR to $115 from $140, citing likely lower fundraising and higher redemptions for KKR's credit and liquid strategies segment. However, its shares are still moderately undervalued even with the fair-value estimate change, the analyst adds. Shares last closed flat at $90.60.(megan.cheah@wsj.com)

 

(END) Dow Jones Newswires

March 20, 2026 03:46 ET (07:46 GMT)

Copyright (c) 2026 Dow Jones & Company, Inc.

应版权方要求,你需要登录查看该内容

免责声明:投资有风险,本文并非投资建议,以上内容不应被视为任何金融产品的购买或出售要约、建议或邀请,作者或其他用户的任何相关讨论、评论或帖子也不应被视为此类内容。本文仅供一般参考,不考虑您的个人投资目标、财务状况或需求。TTM对信息的准确性和完整性不承担任何责任或保证,投资者应自行研究并在投资前寻求专业建议。

热议股票

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10